Patent: 7,273,718
✉ Email this page to a colleague
Summary for Patent: 7,273,718
Title: | Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P |
Abstract: | The invention is directed to an isolated genomic polynucleotide fragment that encodes human soluble (cytosolic) aminopeptidase P, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human soluble aminopeptidase P and to diagnose, treat, prevent and/or ameliorate a pathological disorder. |
Inventor(s): | Ryan; James W. (Augusta, GA) |
Assignee: | Ryogen LLC (Suffern, NY) |
Application Number: | 10/457,715 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,273,718 |
Patent Claims: | see list of patent claims |
Details for Patent 7,273,718
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2022-06-07 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2022-06-07 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2022-06-07 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |